Constitutive activation of NF-κB inducing kinase (NIK) in the mesenchymal lineage using Osterix (Sp7)- or Fibroblast-specific protein 1 (S100a4)-Cre drives spontaneous soft tissue sarcoma.
Aberrant NF-κB signaling fuels tumor growth in multiple human cancer types including both hematologic and solid malignancies. Chronic elevated alternative NF-κB signaling can be modeled in transgenic mice upon activation of a conditional NF-κB-inducing kinase (NIK) allele lacking the regulatory TRAF...
Main Authors: | Jennifer L Davis, Roman Thaler, Linda Cox, Biancamaria Ricci, Heather M Zannit, Fei Wan, Roberta Faccio, Amel Dudakovic, Andre J van Wijnen, Deborah J Veis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0254426 |
Similar Items
-
Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics
by: Biancamaria Ricci, et al.
Published: (2020-08-01) -
Skeletal Deformities in Osterix-Cre;Tgfbr2<sup>f/f</sup> Mice May Cause Postnatal Death
by: Kara Corps, et al.
Published: (2021-06-01) -
NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway
by: Jianyang Xiang, et al.
Published: (2022-01-01) -
Postnatal Osterix but not DMP1 lineage cells significantly contribute to intramembranous ossification in three preclinical models of bone injury
by: Evan G. Buettmann, et al.
Published: (2023-01-01) -
Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
by: Andrew Paul, et al.
Published: (2018-10-01)